aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Maven Capital Partners is an independent alternative asset manager with over £415 million in assets under management. The firm focuses on providing flexible equity and loan finance packages to UK SMEs and funding well-researched property development projects. Maven operates from a nationwide network of regional offices and invests across various stages, including seed, Series A, and Series B rounds.
Notable portfolio companies include Carcinotech, ProofID, redwigwam, Nano Interactive, Pura, and BioAscent. Key decision-makers at Maven include Ishani Malhotra, Tom Eggleston, and Lorna Davidson. Maven's investment philosophy centers on unlocking potential and accelerating growth for businesses. They offer extensive expertise and capital to support the growth of their portfolio companies, enhancing their value through strategic guidance and operational support.
Also Known As
Maven Capital Partners
Operating Status
Acquired
Maven Capital Partners Address
Edinburgh,
City of Edinburgh
eh3 7lb
United Kingdom
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts